Doping suspension lifted after samples didn't match, says Peter Bol

Bol repeated Tuesday that he's never taken banned performance-enhancing substances and he described the last month as a nightmare

Peter Bol
Peter Bol
AP Sydney
2 min read Last Updated : Feb 14 2023 | 4:29 PM IST

Olympic 800-meter finalist Peter Bol on Tuesday said his provisional doping suspension has been lifted after the A and B samples didn't match.

Usually testing of the B sample confirms the original adverse finding in doping cases.

I was just informed that my B sample did not match my A sample, Bol posted on Twitter.

My provisional suspension has been lifted by Sport Integrity Australia.

Sport Integrity Australia later confirmed testing of the B sample by a World Anti-Doping Agency-accredited laboratory showed an atypical finding, but that in itself is not the same as a negative test result.

The investigation into the matter remains ongoing. Sport Integrity Australia will, as part of its investigation, proceed to consider whether any anti-doping rule violations have been committed, the government-backed agency said in a statement.

It is not possible to provide a timeframe at this point.

Bol repeated Tuesday that he's never taken banned performance-enhancing substances and he described the last month as a nightmare.

Athletics Australia announced last month that Bol had failed an out-of-competition test on Oct. 11. The 28-year-old runner's A sample tested positive to the banned drug erythropoietin, known as EPO.

The relief I am feeling is hard to describe. Bol said after the B sample results returned.

The last month has been nothing less than a nightmare. I wish that the results of my A sample had not been leaked, but there is nothing I can do about that.

To say it one more time: I am innocent and have not taken this substance as I was accused."

Bol placed fourth in the 800-meter final at the Tokyo Olympics and was a silver medalist at the 2022 Commonwealth Games.

Richard Ings, the former head of Australia's anti-doping agency, described the differing results from A and B samples as exceedingly rare.

Questions need asking of the lab and how it processed and assessed the A sample," Ings posted on Twitter.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :athletesDopingOlympics

First Published: Feb 14 2023 | 4:29 PM IST

Next Story